http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019189331-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
filingDate | 2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2019189331-A1 |
titleOfInvention | New K95-5901-1 substance and its manufacturing method |
abstract | As a result of searching for an antibiotic effective against multidrug-resistant tubercle bacilli in a microbial culture medium, the present inventors have obtained the following structure from the products of actinopranes sp. K95-5901. A novel substance K95-5901-1 having was discovered. This substance also exhibits growth inhibitory activity against multidrug-resistant tuberculosis bacteria at a low concentration of micromol or less, and has very weak cytotoxicity. Therefore, the present invention provides a novel active substance for inhibiting the growth of Mycobacterium tuberculosis based on such findings. [Selection diagram] None |
priorityDate | 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 637.